Publications
-
1.
2012Sarat Chandarlapaty; Rita A. Sakr; Dilip Giri; Sujata Patil; Adriana Heguy; Monica Morrow; Shanu Modi; Larry Norton; Neal Rosen; Clifford Hudis; et al.
Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer
Clinical Cancer Research. 2012;18(24):6784-6791. -
2.
2012Margaret K. Callahan; Raajit Rampal; James J. Harding; Virginia M. Klimek; Young Rock Chung; Taha Merghoub; Jedd D. Wolchok; David B. Solit; Neal Rosen; Omar Abdel-Wahab; et al.
Progression of RAS-mutant leukemia during RAF inhibitor treatment
New England Journal of Medicine. 2012;367(24):2316-2321. -
3.
2012Piro Lito; Christine A. Pratilas; Eric W. Joseph; Madhavi Tadi; Ensar Halilovic; Matthew Zubrowski; Alan Huang; Wai Lin Wong; Margaret K. Callahan; Taha Merghoub; et al.
Cancer Cell. 2012;22(5):668-682.
Similar Experts
- Publications
- 112










- 336










- 89










- 39










Journals
-
Publications
-
25
-
13
-
13
-
11
-
8
Grants*
-
1.
Neal Rosen
DFCI Pediatric Low-Grade Astrocytoma Program
Dana Farber Cancer Institute
Sponsor: Other
Funding: $ 122,727
-
2.
Neal Rosen
Development of Mechanism-based Therapies for the Treatment of Metastatic Melanoma
Starr Cancer Consortium
Funding: $ 802,541
-
3.
David Solit; Neal Rosen
Targeting BRAF and MEK in tumors with BRAF and RAS mutations.
National Cancer Institute
Funding: $ 1,025,050
*Grants count displayed may not represent all of an Expert's awards. Only awards managed by the Grants & Contracts office are posted.
Institutional Network
-
Internal OrganizationsShared Pub.
-
74









-
72









-
65









-
57









-
22









-
11









-
External OrganizationsShared Pub.
-
31
-
11
-
8
-
8
-
7
-
6




